Antibacterial peptides (ABPs) have been recognized as
promising
alternatives to conventional antibiotics due to their broad antibacterial
spectrum, high antibacterial activity, and low possibility of inducing
bacterial resistance. However, their antibiofilm mechanisms have not
yet reached a consensus. In this study, we investigated the antibiofilm
activity of a short helical peptide G3 against Staphylococcus
epidermidis, one of the most important strains of
medical device contamination. Studies show that G3 inhibits S. epidermidis biofilm formation in a variety of
ways. In the initial adhesion stage, G3 changes the properties of
bacterial surfaces, such as charges, hydrophobicity, and permeability,
by rapidly binding to them, thus interfering with their initial adhesion.
In the mature stage, G3 prefers to target extracellular polysaccharides,
leading to the death of outside bacteria and the disruption of the
three-dimensional (3D) architecture of the bacterial biofilm. Such
efficient antibiofilm activity of G3 endows it with great potential
in the treatment of infections induced by the S. epidermidis biofilm.